It appears that most private companies look at how their health insurance plans impact their budgets rather than how they ...

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look ...

Two months after UnitedHealthcare CEO Brian Thompson was killed, the insurer's parent company is going after people who say ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look ...

Three Democratic states have sued the Trump administration over its order to ban federal funding for gender-affirming care for transgender people under 19 ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

Here are seven attractively valued dividend stocks investors can bet on for the long term, according to Bank of America ...

Skyward Specialty also announced the following fourth quarter 2024 preliminary results and provided 2025 guidance: Highlights for the fourth quarter included: Gross written premiums of $388.4 million, ...

General Catalyst-backed Fay landed the Series B fundraise at a valuation around $500 million.

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...